Zentalis Pharmaceuticals, Inc. Prepaid Expense and Other Assets
Zentalis Pharmaceuticals, Inc. (ZNTL) had Prepaid Expense and Other Assets of $10.80 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets $10.80M.
- 2026-03-31: Prepaid Expense and Other Assets $10.43M.
- 2025-12-31: Prepaid Expense and Other Assets $11.41M.
- 2025-09-30: Prepaid Expense and Other Assets $10.81M.
| Period end | Prepaid Expense and Other Assets | Prepaid Expense and Other Assets as first filed |
|---|---|---|
| 2026-06-30 | $10.80M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $10.43M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $11.41M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $10.81M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $11.39M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $13.77M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $14.40M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $14.63M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $20.07M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $21.67M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $20.62M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $20.14M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $18.86M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $27.20M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $24.29M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $22.40M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $24.34M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $21.83M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $17.68M 10-K · filed 2023-03-01 | $17.68M 10-K · filed 2022-02-24 |
| 2021-09-30 | $16.46M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $13.10M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $10.52M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $9.16M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $9.42M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $8.44M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $4.57M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $3.64M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |